|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PLCE1 |
Basic gene info. | Gene symbol | PLCE1 |
Gene name | phospholipase C, epsilon 1 | |
Synonyms | NPHS3|PLCE|PPLC | |
Cytomap | UCSC genome browser: 10q23 | |
Genomic location | chr10 :95753745-96088148 | |
Type of gene | protein-coding | |
RefGenes | NM_001165979.2, NM_001288989.1,NM_016341.3, | |
Ensembl id | ENSG00000138193 | |
Description | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1PLC-epsilon-1pancreas-enriched phospholipase Cphosphoinositide phospholipase C-epsilon-1phosphoinositide-specific phospholipase C epsilon-1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 608414 | |
HGNC : HGNC | ||
Ensembl : ENSG00000138193 | ||
HPRD : 07087 | ||
Vega : OTTHUMG00000018789 | ||
Protein | UniProt: Q9P212 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PLCE1 | |
BioGPS: 51196 | ||
Gene Expression Atlas: ENSG00000138193 | ||
The Human Protein Atlas: ENSG00000138193 | ||
Pathway | NCI Pathway Interaction Database: PLCE1 | |
KEGG: PLCE1 | ||
REACTOME: PLCE1 | ||
ConsensusPathDB | ||
Pathway Commons: PLCE1 | ||
Metabolism | MetaCyc: PLCE1 | |
HUMANCyc: PLCE1 | ||
Regulation | Ensembl's Regulation: ENSG00000138193 | |
miRBase: chr10 :95,753,745-96,088,148 | ||
TargetScan: NM_001165979 | ||
cisRED: ENSG00000138193 | ||
Context | iHOP: PLCE1 | |
cancer metabolism search in PubMed: PLCE1 | ||
UCL Cancer Institute: PLCE1 | ||
Assigned class in ccmGDB | B - This gene belongs to cancer gene. |
Top |
Phenotypic Information for PLCE1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: PLCE1 |
Familial Cancer Database: PLCE1 |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_INOSITOL_PHOSPHATE_METABOLISM |
Others | |
OMIM | 608414; gene. 608414; gene. 610725; phenotype. 610725; phenotype. |
Orphanet | 93213; Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis. 93213; Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis. 93217; Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis. 93217; Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis. |
Disease | KEGG Disease: PLCE1 |
MedGen: PLCE1 (Human Medical Genetics with Condition) | |
ClinVar: PLCE1 | |
Phenotype | MGI: PLCE1 (International Mouse Phenotyping Consortium) |
PhenomicDB: PLCE1 |
Mutations for PLCE1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
pancreas | PLCE1 | chr10 | 95837172 | 95837192 | chr10 | 95686504 | 95686524 | |
pancreas | PLCE1 | chr10 | 96042277 | 96042297 | PLCE1 | chr10 | 96043292 | 96043312 |
pancreas | PLCE1 | chr10 | 96056637 | 96056657 | PLCE1 | chr10 | 96061171 | 96061191 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PLCE1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
DA374251 | PLCE1 | 1 | 137 | 10 | 95791432 | 95791568 | NEBL | 138 | 543 | 10 | 21071612 | 21072017 | |
AK025366 | PLCE1 | 1 | 1724 | 10 | 96011362 | 96013085 | PLCE1 | 1718 | 2011 | 10 | 96008147 | 96008440 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   | 1 |   | 2 |   |   | 3 |   | 1 |   |   |   | 1 |   |   |   |   | |||
GAIN (# sample) |   |   |   | 2 |   |   | 1 |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   | 1 |   |   |   |   | 2 |   | 1 |   |   |   | 1 |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=153) | (# total SNVs=37) |
(# total SNVs=4) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr10:96030337-96030337 | p.R1495Q | 6 |
chr10:96066363-96066363 | p.V1934V | 3 |
chr10:96084175-96084175 | p.E2191K | 3 |
chr10:95790940-95790940 | p.R46Q | 3 |
chr10:95791355-95791355 | p.R184R | 3 |
chr10:96006017-96006017 | p.N912S | 2 |
chr10:96012148-96012148 | p.N1058H | 2 |
chr10:95791743-95791743 | p.A314S | 2 |
chr10:96058429-96058429 | p.? | 2 |
chr10:96028737-96028737 | p.D1445N | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 5 | 12 | 4 | 28 | 1 |   | 13 |   | 4 |   | 4 | 22 | 13 | 3 | 1 |   | 45 | 18 | 1 | 23 |
# mutation | 5 | 12 | 4 | 33 | 1 |   | 16 |   | 4 |   | 4 | 23 | 14 | 3 | 1 |   | 59 | 23 | 1 | 42 |
nonsynonymous SNV | 3 | 10 | 2 | 28 | 1 |   | 9 |   | 3 |   | 4 | 16 | 11 | 1 | 1 |   | 43 | 11 |   | 33 |
synonymous SNV | 2 | 2 | 2 | 5 |   |   | 7 |   | 1 |   |   | 7 | 3 | 2 |   |   | 16 | 12 | 1 | 10 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr10:95790940 | p.R46Q,PLCE1 | 3 |
chr10:96084175 | p.E1883K,PLCE1 | 3 |
chr10:95791437 | p.D212Y,PLCE1 | 3 |
chr10:96018635 | p.N604S,PLCE1 | 2 |
chr10:95931014 | p.G131C,PLCE1 | 2 |
chr10:95987084 | p.S51F,PLCE1 | 2 |
chr10:95892039 | p.D958Y,PLCE1 | 2 |
chr10:95791949 | p.S1176L,PLCE1 | 2 |
chr10:95987095 | p.G1017D,PLCE1 | 2 |
chr10:95790955 | p.R146R,PLCE1 | 2 |
Other DBs for Point Mutations |
Copy Number for PLCE1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PLCE1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ANKRD36BP1,ARSJ,CADM1,CREB3L2,GREB1L,JMJD1C,KCNQ5, MAML2,MAP2,OSBPL1A,PLCE1,PPL,PTPN14,SDC2, SORBS2,SOX6,SLC35G1,TNFSF15,TRPV4,VEPH1,YAP1 | ANO6,AVPR1A,CDC42BPA,CRYBG3,KATNAL1,KLHL20,LIMS1, TENM3___TENM1,PDE3A,PHLDB2,PIK3CA,PLCE1,PLSCR4,PTPRG, PVRL3,ROCK1,SOX5,SYNE1,TJP1,TMTC1,TTLL7 | ||||
ABCC13,AHCYL2,ATP11B,B3GALT1,CDHR5,CEACAM7,CNNM4, ENTPD5,GPA33,HHLA2,ITM2C,MAGI3,MIER3,MOB3B, MOGAT2,NBEAL1,PDCD4,PLCE1,PLXNA2,SH3RF2,SLC16A9 | ABCC3,ATP8B1,PRR14L,CLMN,DNAJC16,FRYL,FZD5, HIPK2,LARP4B,MAGI3,MAVS,MED14,NBEAL1,PLCE1, PLEKHA6,PRSS12,RREB1,SATB2,TMEM131,TRPM4,ZDHHC23 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for PLCE1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Organism-specific databases | PharmGKB | PA33391; -. |
Organism-specific databases | PharmGKB | PA33391; -. |
Organism-specific databases | CTD | 51196; -. |
Organism-specific databases | CTD | 51196; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00171 | phospholipase C, epsilon 1 | approved; nutraceutical | Adenosine triphosphate | ||
DB00770 | phospholipase C, epsilon 1 | approved; investigational | Alprostadil | ||
DB00668 | phospholipase C, epsilon 1 | approved | Epinephrine |
Top |
Cross referenced IDs for PLCE1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |